HOTLINE:4008-338-568
Solution

The current position: Home > Solution > POCT定量快速检测平台

The optimal solution forthe POCT quantitative rapid testing platform

Immunoassay Quantitative Analysis System:    



GR200 Immunoassay Quantitative Analyzer

FR300 Dry Fluorescence Immunoassay Analyzer


Product advantages:

·High standards: quantitative detection, multiple quality control, with the accurate and stable results

·High intelligence: automatic identification, full-automated detection with one

button, Effective docking hospital lis system and automatic uploading data

·High efficiency: real-time detection, automatic detection within 20 minutes, realizing fast batch testing

·High flexible: a variety of supplementary reagents, covering heart, inflammation, kidney and other fields


Supporting reagents and clinical application:

·Cardiac markers

Cardiac Troponin I / Myoglobin / Creatine Kinase Isoenzyme MB(cTnI/Myo/CK-MB)

Clinical application: 

Early diagnosis of acute coronary syndrome;                                                          

The prognosis and risk stratification of acute coronary syndrome evaluation;                                              

The forecast of myocardial infarction area;                                                                           

The indicator of thrombolysis and interventional therapy after acute myocardial infarction;                                                  

Differential diagnosis of chest pain reasons;                                

The evaluation of clinical therapeutic effect.  

Application department: cardiology department (outpatient clinic, and ward and CCU); emergency department (120 ambulance, ICU); Clinical laboratory, etc.  

Triad detection, including cTnI, Myo and CK-MB, can effectively avoid missed diagnosis and misdiagnosis.


Heart-type fatty acid binding-protein (H-FABP)

Clinical application: 

The earliest sensitive parameter of AMI diagnosis;

The forecast of myocardial infarction area;

The diagnosis and monitoring of traumatic myocardial injury;

Recent predict cardiovascular events after coronary stent.

Early detection of H-FABP and Myo, and convalescent of cTnI and CK-MB, is helpful to select high-risk patients with myocardial damage.


N-terminal pro-brain B-type natriuretic peptides(NT-proBNP)

Clinical application: 

Prevention and detection of heart failure;                                                                           

Monitoring and evaluation of heart failure therapy;                                         

Diagnosis and risk stratification of heart failure;                                       

Risk stratification of acute coronary syndrome (ACS);                                 

Identification of heart failure and other reasons caused by breathing difficulties.

Application department: cardiology department (outpatient clinic, and ward and CCU); emergency department (120 ambulance, ICU); pneumology Department, thoracic surgery, etc.


·Inflammatory Markers

Procalcitonin(PCT)

Clinical application: The identification of bacterial and viral infections;

Identification and diagnosis of sepsis, assessment of the severity of the sepsis and disease progression, and prognosis of sepsis judgment;

Accurate guidance for the use of antibiotic, avoiding the abuse of antibiotics;

The differential diagnosis of fever infection after the surgery, radiotherapy and chemotherapy.

Application department: infections department, pediatrics, respiratory infection, emergency department, cardiology, oncology, surgical department, etc.


The use of PCT in the sepsis (ICU):

PCT< 0.5ng/ml  Showing that sepsis is extremely unlikely;

PCT> 2 ng/ml  Indicating that sepsis could escalate to septic shock.

1)PCT guiding the use of antibiotics

PCT< 0.1ng/ml  Basic without the possibility of bacterial infection, not strongly

recommend the use of antibiotics;

PCT:0.1-0.25ng/ml  Bacterial infection is unlikely, whether to use antibiotics

should combined with clinical symptoms;

PCT:0.25-0.5ng/ml  There may be a need to treat bacterial infections and recommend the use of antibiotics;

PCT> 0.5 ng/ml  No doubt in need of treatment of bacterial infections, strongly recommend the use of antibiotic.


C-reactive protein(hs-CRP+CRP)

Clinical application:

The identification of bacterial and viral infections;

Effect evaluation of antibiotic treatment;

The detection and postoperative monitoring in inflammatory disease;

The risk of cardiovascular disease and treatment evaluation.

Application department: Clinical laboratory, infections department, pediatrics, pneumology department, emergency department, cardiology department, surgical department, etc.

Severity judgment of conventional inflammation

CRP>50 ug/ml  Serious bacterial infection;

CRP:20-50 ug/ml  General bacterial infections;

CRP:10-20 ug/ml  Viral or bacterial infection.

1)Cardiovascular severe judgment

hs CRP<1 ug/ml  Low sick;

hs CRP :1-3 ug/ml  Moderate risk;

hs CRP>3 ug/ml  Highly dangerous.


·Thrombus

D-Dimer

Clinical application: 

Exclusion and auxiliary diagnosis of deep venous thrombosis(DVT)and pulmonary embolism(PE);

Diagnosis of disseminated intravascular coagulation(DIC);

Surgery and thrombolytic therapy monitoring;

Diagnosis and detection of high coagulation state of pregnancy-induced hypertension syndrome;

Auxiliary diagnosis and prognosis of cerebral infarction.

Application department: cardiology department, emergency department, pneumology department, neurology department, surgical department, etc.

1)Suspected deep vein thrombosis(DVT)in clinic

D-Dimer<0.5 ng/mL,Eliminating DVT;

D-Dimer>0.5 ng/mL,Perfoming ultrasonic inspection, if positive, then must be treated with DVT, if negative, considering other clinical possibilities.

2)Suspected pulmonary embolism(PE)in clinic

D-Dimer<0.5 ng/mL,Eliminating PE;

D-Dimer>0.5 ng/mL,Perfoming ultrasonic inspection, if positive, then must be treated with PE, if negative, make a definite diagnosis with ventilation/perfusion scans .